Explore / Clinical trial
Clinical trial

The 'Wearing Off' Effect of DMT

Novartis PharmaceuticalsCompletedStarted Jan 10, 202339 enrolledSwitzerlandNCT05627271

Abstract

This is a non-interventional, cross-sectional, qualitative study in which patients diagnosed with MS and clinicians with experience treating MS will be interviewed regarding patient experiences with the wearing off effect from ocrelizumab, natalizumab, and ofatumumab

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

DMT

Keywords

Multiple SclerosisMSocrelizumabOcrevusnatalizumabTysabriofatumumabKesimptaNISMultiple Sclerosis

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.